Company intelligence / Profile preview

Squibb Iran

Tehran, Iran

Ownership: Private
Development stage: Other

Overview

Squibb Iran was the Iranian subsidiary of the American pharmaceutical giant E.R. Squibb & Sons, established prior to the 1979 Iranian Revolution. The company operated a significant manufacturing facility in Tehran, producing a variety of pharmaceutical products including antibiotics and general medicines for the local market. Following the revolution, the company's assets were nationalized by the Iranian government. The entity was subsequently renamed Jaber Ebne Hayyan Pharmaceutical Company, which continues to operate today as one of Iran's major pharmaceutical manufacturers.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Squibb Iran.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Squibb Iran.

Explore the full profile